Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technical analysis for shorts & longs -- Ignore unavailable to you. Want to Upgrade?

To: Clint E. who wrote (28068)	9/9/2000 10:16:11 AM
From: Return to Sender	Read Replies (1) \| Respond to of 68291

Among the bigger name Biotechs that are oversold INCY still remains on my screen. PDLI has already begun to move strongly back higher on the basis of good news. ABSC showed up on the screen for the first time in a long time last night. I believe that it might be due for a dip below 60 again before it will rebound but good news could turn it around without that happening too. GLIA has found a base at 7 1/2 and for those who wish to truly speculate that the FDA won't pull their one product off the market this could be a tremendous buying opportunity. finance.yahoo.com Speculative oversold buy signals: ABSC on a dip below 60. Closed at 60 15/16's on Friday. GLIA cautious buy as close to 7 1/2 as possible. INCY buy signal generated at 36 1/2 on Wednesday September 5. PDLI buy signal generated at 80 3/4's on Wednesday Sept 5th. Closed on Friday at 92 11/16. There are now 12 Biotech and Drug stocks on my oversold screen. On Thursday it was only 9. The generation of oversold buy signals based on my limited use of technical analysis is for information purposes only and should not be confused with any recommendation to buy these securities without first doing your own due diligence and contacting a suitably qualified investment professional. RTS